Kaken Pharmaceutical Co., Ltd. (4521.T) JPX

3,790.00

+5(+0.13%)

Updated at June 03 03:23PM

Currency In JPY

Valuation

Market Cap156.95B
Enterprise Value116.09B
P/E Ratio66.71
PEG Ratio-0.4
Price/Sales Ratio1.86
Price/Book Ratio0.97
Enterprise/Revenue1.33
Enterprise/EBITDA26.25

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.03
Operating Margin-0.01

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue76.87B
Revenue/Share2,029.06
Gross Profit39.24B
EBITDA2.43B
Net Income2.14B
Diluted EPS56.55

Balance Sheet

Total Cash50.71B
Total Cash/Share1,338.39
Total Debt3.85B
Total Debt/Equity0.03
Current Ratio4.52
Book Value Per Share3,896.58

Price History

52-Week Change-0.32
52-Week High4,445
52-Week Low3,540
Moving Average 50 Days4,115
Moving Average 200 Days3,990.4

Statistics

Average Volume123,255
Shares Outstanding37.87M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate190
Trailing Annual Dividend Yield5.03
Payout Ratio0
Last Split Factor1:2
Last Split DateSeptember 28, 2015